Media/Policy Watch

Media/Policy Watch

This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
Accessed 24 February 2018
Japan’s New Drug: One Pill May Stop The Flu in Just One Day
Bruce Y. Lee, Contributor
On Friday, Japanese pharmaceutical company Shionogi announced that Xofluza has been approved to be manufactured and sold in Japan. How does it work and when will it be available in the U.S.
The Guardian
Accessed 24 February 2018
I understand the fears. But vaccinating children should be compulsory
22 February 2018
Engaging the emotional intelligence of the public is the way to sell the scientific fact that immunisation prevents deaths

Trump appears to abandon vaccine sceptic group denounced by scientists
21 February 2018
Robert F Kennedy Jr claimed to be leading a review of links to autism – a widely debunked claim – but now says he hasn’t heard from the White House in months.
New York Times
Accessed 24 February 2018
Business Day
U.S. Health Officials Reverse Stance on AstraZeneca’s Flu Vaccine
AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.
Feb 21, 2018

Wall Street Journal,us&_homepage=/home/us
Accessed 24 February 2018
The Numbers
The Math Behind Flu Season
By Jo Craven McGinty
Feb. 23, 2018 8:00 am ET
The U.S. relies on a network of hospitals,​laboratories and outpatient facilities to track the flu each year, but the effort captures only a fraction of the cases.

Washington Post
Accessed 24 February 2018
Brazil battles yellow fever — and a ‘dangerous’ anti-vaccination campaign
18 Feb 2018.